Answers are grounded in this paper and cite their sources.
Protein detection technologies are important for early disease diagnosis because of their advantages over biopsy testing. Considering the diagnostic potential of prostate‐specific antigen (PSA) in prostate cancer, in this study, we present a lateral flow immunoassay (LFIA) for successful detection of PSA by using silica‐coated CdSe@ZnS quantum dots (QD@SiO2). The QD@SiO2 were synthesized using a reverse microemulsion method. The average size of the synthesized nanoparticles (NPs) was 51.76 nm, and their quantum yield (QY) was relatively high (36.5%). PSA detection was performed using LFIA on a strip. The QD@SiO2 surface was modified by conjugating the anti‐PSA antibody to detect the PSA. At concentrations above 1.0754 ng/mL, PSA was detected using the designed LFIA system without any nonspecific binding. The proposed QD@SiO2 has other bioapplications as well.
No takes yet. Share an insight, caveat, or question.
Bock et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: